MARK SMOLENSKI: Open Payments
NPI 1467571257 · MOUNTAIN VIEW, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$287 in 4 payments from 3 companies in 2025. Trend: 2023 $743 · 2024 $1,760 · 2025 $287
Food & beverage: $287
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 1 | $118 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $116 |
| ABBVIE INC. | 2 | $53 |
Products named: LYBALVI, CAPLYTA, VRAYLAR.
Industry payments across CA — which companies pay providers there.
